TuHURA Biosciences (STU:PL3) Interest Expense: €-0.56 Mil (TTM As of Mar. 2026)


STU:PL3 TuHURA Biosciences Inc STU:PL3
14 GF Score
Price €1.96
! 1 Warning Sign
View Full Analysis

What is TuHURA Biosciences Interest Expense?

TuHURA Biosciences STU:PL3 +0.51% 14 Interest Expense is €-0.56 Mil as of Mar. 2026. GuruFocus rates STU:PL3 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. TuHURA Biosciences's interest expense for the three months ended in Mar. 2026 was € -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.56 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. TuHURA Biosciences's Operating Income for the three months ended in Mar. 2026 was € -6.51 Mil. TuHURA Biosciences's Interest Expense for the three months ended in Mar. 2026 was € -0.02 Mil. TuHURA Biosciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TuHURA Biosciences  (STU:PL3) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TuHURA Biosciences's Interest Expense for the three months ended in Mar. 2026 was €-0.02 Mil. Its Operating Income for the three months ended in Mar. 2026 was €-6.51 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €0.22 Mil.

TuHURA Biosciences's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

TuHURA Biosciences did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

TuHURA Biosciences Interest Expense Historical Data

* Premium members only.

The historical data trend for TuHURA Biosciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TuHURA Biosciences Interest Expense Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
-0.56 0.00 -0.02 -3.95 -0.53

TuHURA Biosciences Quarterly Data
Dec21 Mar22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.01 -0.52 -0.02
STU:PL3
14GF Score
TuHURA Biosciences Inc STU:PL3
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TuHURA Biosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-0.56 Mil mean?
TuHURA Biosciences (STU:PL3) has a Interest Expense of €-0.56 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on TuHURA Biosciences and its competitors.
Is TuHURA Biosciences' Interest Expense too high?
TuHURA Biosciences' current Interest Expense is €-0.56 Mil. Overall, TuHURA Biosciences has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' Interest Expense compare to ACOG and MENS?
TuHURA Biosciences' Interest Expense of €-0.56 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on TuHURA Biosciences and its competitors. TuHURA Biosciences's current Interest Expense is €-0.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (STU:PL3) has a current Interest Expense of €-0.56 Mil. The current Interest Expense is €-0.56 Mil. TuHURA Biosciences' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For TuHURA Biosciences (STU:PL3), the current Interest Expense is €-0.56 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges HURA:USA
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
14GF Score

Get the complete analysis for STU:PL3

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.96
Price